Literature DB >> 15034009

Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells.

Gary K Koski1, Katalin Karikó, Shuwen Xu, Drew Weissman, Peter A Cohen, Brian J Czerniecki.   

Abstract

RNA derived from bacterial but not eukaryotic sources, when transfected into human monocyte-derived dendritic cell precursors, induces high-level IL-12 secretion in conjunction with dendritic cell maturation stimuli. In vitro-transcribed mRNA that mimics the structure of bacterial mRNA in the lack of a long 3'-poly(A) tail likewise induces IL-12 secretion, but this property is lost upon efficient enzymatic 3'-polyadenylation. Among other tested RNAs, only polyuridylic acid induced IL-12 p70. This RNA response phenomenon appears biologically distinct from the classically defined response to dsRNA. RNA-transfected APC also polarize T cells in an IL-12-dependent manner toward the IFN-gamma(high)IL-5 (low) Th1 phenotype, suggesting a link between the detection of appropriately structured RNA and the skewing of immune responses toward those best suited for controlling intracellular microbes. RNA structured to emulate bacterial patterns constitutes a novel vaccine strategy to engender polarized Th1-type immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034009     DOI: 10.4049/jimmunol.172.7.3989

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  mRNA: Fulfilling the Promise of Gene Therapy.

Authors:  Drew Weissman; Katalin Karikó
Journal:  Mol Ther       Date:  2015-09       Impact factor: 11.454

2.  Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Authors:  Abdul Q Khan; Quanyi Chen; Zheng-Qi Wu; James C Paton; Clifford M Snapper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Dendritic cells in melanoma immunotherapy.

Authors:  Mark B Faries; Brian J Czerniecki
Journal:  Curr Treat Options Oncol       Date:  2005-05

4.  Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells.

Authors:  Giuseppe Mancuso; Maria Gambuzza; Angelina Midiri; Carmelo Biondo; Salvatore Papasergi; Shizuo Akira; Giuseppe Teti; Concetta Beninati
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

5.  Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.

Authors:  Hiroyuki Tada; Setsuya Aiba; Ken-Ichiro Shibata; Toshiaki Ohteki; Haruhiko Takada
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.

Authors:  A Escobar; M López; A Serrano; M Ramirez; C Pérez; A Aguirre; R González; J Alfaro; M Larrondo; M Fodor; C Ferrada; F Salazar-Onfray
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

7.  JAK kinases are required for the bacterial RNA and poly I:C induced tyrosine phosphorylation of PKR.

Authors:  Farag Bleiblo; Paul Michael; Danielle Brabant; Chilakamarti V Ramana; Tc Tai; Mazen Saleh; Joseph E Parrillo; Anand Kumar; Aseem Kumar
Journal:  Int J Clin Exp Med       Date:  2012-11-18

8.  Bacterial RNA induces myocyte cellular dysfunction through the activation of PKR.

Authors:  Farag Bleiblo; Paul Michael; Danielle Brabant; Chilakamarti V Ramana; Tc Tai; Mazen Saleh; Joseph E Parrillo; Anand Kumar; Aseem Kumar
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

9.  Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis.

Authors:  Julio C C Lorenzi; Ana P F Trombone; Carolina D Rocha; Luciana P Almeida; Ricardo L Lousada; Thiago Malardo; Isabela C Fontoura; Renata A M Rossetti; Ana F Gembre; Aristóbolo M Silva; Celio L Silva; Arlete A M Coelho-Castelo
Journal:  BMC Biotechnol       Date:  2010-10-20       Impact factor: 2.563

Review 10.  The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Authors:  Sergio Romagnani
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.